65/73
  • Pages
  • Editions
01 Cover
02 Welcome Letter / Sections
03 Article & Interview Directory
04 Section 1: Introduction
05 Introduction to US Life Sciences
06 Janssen Pharmaceuticals Interview
07 Investment Climate
08 MPM Capital Interview
09 Signet Healthcare Partners Interview
10 Xontogeny Interview
11 Insights from EisnerAmper
12 The Life Sciences Regulatory Climate
13 Buchanan Ingersoll & Rooney PC Interview
14 PhRMA Interview
15 PBOA Interview
16 Ernst & Young LLP Interview
17 LaVoieHealthScience Interview
18 Section 2: Introducing the Hubs
19 East Coast
20 BioNJ Interview
21 MassBio Interview
22 Pennsylvania Biotechnology Center Interview
23 West Coast
24 Biocom California Interview
25 QB3-Berkeley Interview
26 Section 3: Drug Discovery and Development
27 Therapeutic Fields On Fire
28 Insmed Interview
29 Mammoth Biosciences Interview
30 Innovations Enhancing the Patient Experience
31 Arcturus Therapeutics Interview
32 Karius Interview
33 Expert Insights: Targeted Therapeutics
34 First Wave BioPharma Interview
35 Aphios Corporation Interview
36 Section 4: Contract Manufacturing and Chemicals
37 A Shifting Landscape
38 Syngene International Interview
39 Cambrex Interview
40 Lubrizol Life Science Interview
41 Aenova Group Interview
42 Keeping Up With Demands
43 Cureline Interview
44 Interview: Murli Krishna Pharma
45 PsychoGenics Interview
46 Expert Insights: Innovative Technologies
47 AMPAC Fine Chemicals Interview
48 TCG Lifesciences Interview
49 CordenPharma Interview
50 Quotient Sciences Interview
51 A Post-Pandemic World
52 New Vision Pharmaceuticals Interview
53 Adare Pharma Solutions Interview
54 Ascendia Pharmaceuticals Interview
55 Chemicals Producers and Distributors
56 Brenntag North America Interview
57 BASF Pharma Solutions Interview
58 Section 5: Technology Services
59 Life Sciences Go Digital
60 RxS Interview
61 Insights from Markem-Imaje
62 AiCure Interview
63 WhizAI Interview
64 Section 6: Company Profiles
65 Brenntag Company Profile
66 Adare Pharma Solutions Company Profile
67 Quotient Sciences Company Profile
68 SK pharmteco Company Profile
69 AiCure Company Profile
70 Markem-Imaje Company Profile
71 TCG Lifesciences Company Profile
72 Murli Krishna Pharma Company Profile
73 Credits

COMPANY PROFILE


"Our goal is clearly defined: We want to lead Brenntag to sustainable success, position the company for the future and strengthen and expand our position as a global market leader."

Christian Kohlpaintner, CEO Brenntag SE

Summary


Brenntag is the global market leader in a full-line range of chemical & ingredient products and value-added services. Our more than 17,000 employees provide tailor-made application, marketing and supply chain solutions. Our full-line portfolio comprises specialty and industrial chemicals and ingredients of a world-class supplier base. Building on its long-standing experience, unmatched global reach, and local excellence, Brenntag works closely alongside its partners to make their business more successful. Brenntag operates a unique global network with about 700 locations in 78 countries. Having entered the chemical distribution business in 1912, Brenntag has successfully expanded to become the global market leader in the distribution of specialty and industrial chemicals, chemical products, and ingredients. We offer a product portfolio consisting of more than 10,000 chemicals and ingredients for a variety of industries.

Key Leadership


• Scott Leibowitz, Regional President, Brenntag Essentials North America • Lars Schneider, Regional President, Brenntag Specialties Americas • Donovan Mattole, Vice President HR, Americas • Leslie Reeve, Vice President Legal, North America • Jeff Rudy, Vice President, Supply Chain, Americas • Dieter Woehrle, Senior Vice President, Finance, Americas • Viktor Alvarado, Vice President Controlling – Brenntag Specialties, Americas

Dr. Christian Kohlpaintner, Chief Executive Officer: The Ph.D chemist Dr Christian Kohlpaintner has more than 25 years of management experience in the chemical industry. This includes international executive roles in both China and the US where he lived and worked for several years each. Dr Christian Kohlpaintner is Member of the Board of Directors of the EPCA European Petrochemical Association and a permanent guest in the Präsidium of Verband der Chemischen Industrie (VCI).

Dr. Kristin Neumann, Chief Financial Officer: The Ph.D. economist Dr Kristin Neumann has several years of management experience with various leadership roles in Germany and also one in the UK. Dr Kristin Neumann also has many years of professional experience in finance and accounting.

Henri Nejade, Chief Operating Officer Brenntag Specialties: Henri Nejade has extensive international management experience with more than 30 years in chemical industry and chemical distribution. Henri Nejade joined Brenntag in 2008 and has held international leadership positions in Asia, Europe and on a global level since then. Henri Nejade is chairman of the Singapore Chemical Industry Council (SCIC), the official industry association representing the Singapore Energy and Chemicals cluster in the private sector.

Steven Terwindt, Chief Operating Officer Brenntag Essentials: Steven Terwindt has more than 20 years of professional experience in the chemical distribution sector. Steven Terwindt joined Brenntag in 1998 and has held various international management positions at Brenntag in Latin, Central and North America since then.

Ewout van Jarwaarde, Chief Transformation Officer: Ewout van Jarwaarde has several years of executive management experience driving growth, transforming organizations, and driving commercial and operational excellence. Ewout van Jarwaarde has been building digital- and data-driven capabilities across various industries globally to unlock value for customers and supply partners.

Additional Resources


Contact

Twitter

LinkedIn

Facebook

Website

Next:

Company Profile: Adare Pharma Solutions